Literature DB >> 34089832

Intratumoral steroid profiling of adrenal cortisol-producing adenomas by liquid chromatography- mass spectrometry.

James P Teuber1, Kazutaka Nanba2, Adina F Turcu3, Xuan Chen4, Lili Zhao4, Tobias Else3, Richard J Auchus5, William E Rainey6, Juilee Rege7.   

Abstract

Endogenous Cushing syndrome (CS) is an endocrine disorder marked by excess cortisol production rendering patients susceptible to visceral obesity, dyslipidemia, hypertension, osteoporosis and diabetes mellitus. Adrenal CS is characterized by autonomous production of cortisol from cortisol-producing adenomas (CPA) via adrenocorticotropic hormone-independent mechanisms. A limited number of studies have quantified the steroid profiles in sera from patients with CS. To understand the intratumoral steroid biosynthesis, we quantified 19 steroids by mass spectrometry in optimal cutting temperature compound (OCT)-embedded 24 CPA tissue from patients with overt CS (OCS, n = 10) and mild autonomous cortisol excess (MACE, n = 14). Where available, normal CPA-adjacent adrenal tissue (AdjN) was also collected and used for comparison (n = 8). Immunohistochemistry (IHC) for CYP17A1 and HSD3B2, two steroidogenic enzymes required for cortisol synthesis, was performed on OCT sections to confirm the presence of tumor tissue and guided subsequent steroid extraction from the tumor. LC-MS/MS was used to quantify steroids extracted from CPA and AdjN. Our data indicated that CPA demonstrated increased concentrations of cortisol, cortisone, 11-deoxycortisol, corticosterone, progesterone, 17OH-progesterone and 16OH-progesterone as compared to AdjN (p < 0.05). Compared to OCS, MACE patient CPA tissue displayed higher concentrations of corticosterone, 18OH-corticosterone, 21-deoxycortisol, progesterone, and 17OH-progesterone (p < 0.05). These findings also demonstrate that OCT-embedded tissue can be used to define intra-tissue steroid profiles, which will have application for steroid-producing and steroid-responsive tumors.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cortisol-producing adenoma; LC–MS/MS; Mild autonomous cortisol excess; OCT-embedded tissue; Overt Cushing syndrome; Steroid profiling

Mesh:

Substances:

Year:  2021        PMID: 34089832      PMCID: PMC8734951          DOI: 10.1016/j.jsbmb.2021.105924

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   5.011


  40 in total

1.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.

Authors:  Lynnette K Nieman; Beverly M K Biller; James W Findling; John Newell-Price; Martin O Savage; Paul M Stewart; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-03-11       Impact factor: 5.958

2.  Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor.

Authors:  J L Arriza; C Weinberger; G Cerelli; T M Glaser; B L Handelin; D E Housman; R M Evans
Journal:  Science       Date:  1987-07-17       Impact factor: 47.728

3.  Advancement in steroid hormone analysis by LC-MS/MS in clinical routine diagnostics - A three year recap from serum cortisol to dried blood 17α-hydroxyprogesterone.

Authors:  Alexander Gaudl; Jürgen Kratzsch; Uta Ceglarek
Journal:  J Steroid Biochem Mol Biol       Date:  2019-05-31       Impact factor: 4.292

4.  Plasma Steroid Profiles in Subclinical Compared With Overt Adrenal Cushing Syndrome.

Authors:  Jimmy Masjkur; Matthias Gruber; Mirko Peitzsch; Denise Kaden; Guido Di Dalmazi; Martin Bidlingmaier; Stephanie Zopp; Katharina Langton; Julia Fazel; Felix Beuschlein; Stefan Richard Bornstein; Martin Reincke; Graeme Eisenhofer
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

5.  Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks.

Authors:  Kazutaka Nanba; Kei Omata; Celso E Gomez-Sanchez; Constantine A Stratakis; Andrew P Demidowich; Mari Suzuki; Lester D R Thompson; Debbie L Cohen; James M Luther; Lan Gellert; Anand Vaidya; Justine A Barletta; Tobias Else; Thomas J Giordano; Scott A Tomlins; William E Rainey
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

Review 6.  Genomics of benign adrenocortical tumors.

Authors:  Anne Jouinot; Roberta Armignacco; Guillaume Assié
Journal:  J Steroid Biochem Mol Biol       Date:  2019-06-14       Impact factor: 4.292

Review 7.  Clinical review: Diagnosis and treatment of subclinical hypercortisolism.

Authors:  Iacopo Chiodini
Journal:  J Clin Endocrinol Metab       Date:  2011-03-02       Impact factor: 5.958

8.  11-Oxygenated C19 Steroids Do Not Decline With Age in Women.

Authors:  Aya T Nanba; Juilee Rege; Jianwei Ren; Richard J Auchus; William E Rainey; Adina F Turcu
Journal:  J Clin Endocrinol Metab       Date:  2019-07-01       Impact factor: 5.958

Review 9.  Approach to the patient with an adrenal incidentaloma.

Authors:  Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2010-09       Impact factor: 5.958

10.  Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome.

Authors:  Felix Beuschlein; Martin Fassnacht; Guillaume Assié; Davide Calebiro; Constantine A Stratakis; Andrea Osswald; Cristina L Ronchi; Thomas Wieland; Silviu Sbiera; Fabio R Faucz; Katrin Schaak; Anett Schmittfull; Thomas Schwarzmayr; Olivia Barreau; Delphine Vezzosi; Marthe Rizk-Rabin; Ulrike Zabel; Eva Szarek; Paraskevi Salpea; Antonella Forlino; Annalisa Vetro; Orsetta Zuffardi; Caroline Kisker; Susanne Diener; Thomas Meitinger; Martin J Lohse; Martin Reincke; Jérome Bertherat; Tim M Strom; Bruno Allolio
Journal:  N Engl J Med       Date:  2014-02-26       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.